Bridging Data Science and Engineering for Sustainable Banking Experience
Source Node: 1963847
Time Stamp: Apr 10, 2024
Social Good
Quantum News Briefs: April 10, 2024: Advanced imaging techniques on a semiconductor material reveal ‘surprising’ hidden activity; D-Wave’s Qubits 2024 Quantum Computing Conference Announced for June 17-18 in Boston; “Quantum rush: Denver-Boulder area aims to be the Silicon Valley of the future”; and MORE! – Inside Quantum Technology
Source Node: 1963103
Time Stamp: Apr 10, 2024
French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics
Source Node: 1961157
Time Stamp: Apr 3, 2024
Vitalik believes memecoins should be used for philanthropy and social impact
Source Node: 1960130
Time Stamp: Mar 29, 2024
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
Source Node: 1960330
Time Stamp: Mar 29, 2024
Research Visioning for Positive Impact of Automated Systems » CCC Blog
Source Node: 1953560
Time Stamp: Mar 4, 2024
Breaking Barriers: Opera MiniPay Surpasses 1 Million Users, Paving the Way for a Digital Financial Revolution in Africa
Source Node: 1950270
Time Stamp: Feb 22, 2024
Here Are The Top 7 Fastest Growing Fintechs in Singapore – Fintech Singapore
Source Node: 1941567
Time Stamp: Jan 24, 2024
IQT Nordics Update: Vishal Chatrath, CEO and Co-Founder of QuantrolOx is a Speaker – Inside Quantum Technology
Source Node: 1935734
Time Stamp: Jan 10, 2024
South Korea Implements Crypto Asset Reporting for Public Officials
Source Node: 1930159
Time Stamp: Dec 27, 2023
YieldMax Unveils New ETF Focused on MicroStrategy Derivatives
Source Node: 1922670
Time Stamp: Dec 8, 2023
Champion REIT Illuminated Hong Kong CBD by “Sharelebrating” Joy with Community at its Premium Property Three Garden Road
Source Node: 1921372
Time Stamp: Dec 5, 2023
Blockchain for Good: The Ambitious Philanthropy of Philcoin in the Heart of Brazil
Source Node: 1914401
Time Stamp: Nov 16, 2023
Eisai Launches New “Innovation” Page on Corporate Website
Source Node: 1895558
Time Stamp: Sep 28, 2023
“LEQEMBI Intravenous Infusion” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan
Source Node: 1893980
Time Stamp: Sep 25, 2023